PDB Short entry for 2HCT HEADER HYDROLASE 18-JUN-06 2HCT TITLE ACIDIC RESIDUES AT THE ACTIVE SITES OF CD38 AND ADP-RIBOSYL CYCLASE TITLE 2 DETERMINE NAAPD SYNTHESIS AND HYDROLYSIS ACTIVITIES COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYL CYCLASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ENZYMATIC DOMAIN, RESIDUES 45-300; COMPND 5 SYNONYM: CYCLIC ADP-RIBOSE HYDROLASE 1, CADPR HYDROLASE 1, LYMPHOCYTE COMPND 6 DIFFERENTIATION ANTIGEN CD38, T10, ACUTE LYMPHOBLASTIC LEUKEMIA CELLS COMPND 7 ANTIGEN CD38; COMPND 8 EC: 3.2.2.5; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD38; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPICZAA KEYWDS BETA SHEETS, ALPHA BUNDLE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR Q.LIU,I.A.KRIKSUNOV,Q.HAO,R.GRAEFF,H.C.LEE REVDAT 6 30-AUG-23 2HCT 1 REMARK REVDAT 5 20-OCT-21 2HCT 1 REMARK SEQADV REVDAT 4 13-JUL-11 2HCT 1 VERSN REVDAT 3 24-FEB-09 2HCT 1 VERSN REVDAT 2 31-OCT-06 2HCT 1 JRNL REVDAT 1 22-AUG-06 2HCT 0 JRNL AUTH R.GRAEFF,Q.LIU,I.A.KRIKSUNOV,Q.HAO,H.C.LEE JRNL TITL ACIDIC RESIDUES AT THE ACTIVE SITES OF CD38 AND ADP-RIBOSYL JRNL TITL 2 CYCLASE DETERMINE NICOTINIC ACID ADENINE DINUCLEOTIDE JRNL TITL 3 PHOSPHATE (NAADP) SYNTHESIS AND HYDROLYSIS ACTIVITIES. JRNL REF J.BIOL.CHEM. V. 281 28951 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16861223 JRNL DOI 10.1074/JBC.M604370200 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 35348 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1856 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2142 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE SET COUNT : 108 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4006 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 257 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.61000 REMARK 3 B22 (A**2) : 1.56000 REMARK 3 B33 (A**2) : 1.42000 REMARK 3 B12 (A**2) : 1.17000 REMARK 3 B13 (A**2) : 0.81000 REMARK 3 B23 (A**2) : 1.95000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.189 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.172 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.182 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.409 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4164 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5648 ; 1.459 ; 1.946 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 502 ; 6.311 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 192 ;38.354 ;23.958 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 708 ;17.816 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;20.570 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 600 ; 0.098 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3150 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1936 ; 0.228 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2800 ; 0.310 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 237 ; 0.179 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 53 ; 0.171 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 19 ; 0.158 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2552 ; 0.834 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4046 ; 1.469 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1845 ; 2.204 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1602 ; 3.532 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 45 A 296 REMARK 3 ORIGIN FOR THE GROUP (A): 0.0727 -0.2767 0.8041 REMARK 3 T TENSOR REMARK 3 T11: -0.2126 T22: -0.1738 REMARK 3 T33: -0.1876 T12: -0.0126 REMARK 3 T13: -0.0035 T23: 0.0358 REMARK 3 L TENSOR REMARK 3 L11: 2.9548 L22: 5.1593 REMARK 3 L33: 0.9069 L12: -1.2275 REMARK 3 L13: -0.0206 L23: -0.7529 REMARK 3 S TENSOR REMARK 3 S11: -0.0301 S12: -0.1702 S13: -0.4622 REMARK 3 S21: 0.3510 S22: 0.0145 S23: -0.1316 REMARK 3 S31: -0.0144 S32: 0.0348 S33: 0.0157 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 45 B 296 REMARK 3 ORIGIN FOR THE GROUP (A): 19.1572 8.6088 -28.5241 REMARK 3 T TENSOR REMARK 3 T11: -0.1394 T22: -0.1118 REMARK 3 T33: -0.1241 T12: 0.0107 REMARK 3 T13: -0.0276 T23: -0.0550 REMARK 3 L TENSOR REMARK 3 L11: 3.3901 L22: 1.7298 REMARK 3 L33: 6.0752 L12: 0.3226 REMARK 3 L13: -0.1448 L23: 0.6094 REMARK 3 S TENSOR REMARK 3 S11: -0.0163 S12: 0.6078 S13: -0.5918 REMARK 3 S21: -0.2732 S22: 0.0329 S23: 0.0563 REMARK 3 S31: 0.5778 S32: -0.0709 S33: -0.0166 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HCT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038204. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-FEB-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : ADSC REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37216 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1YH3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES, 12% PEG 4000, PH 6.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS TWO BIOLOGICAL UNITS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 39 REMARK 465 ARG A 40 REMARK 465 GLU A 41 REMARK 465 ALA A 42 REMARK 465 GLU A 43 REMARK 465 ALA A 44 REMARK 465 THR A 297 REMARK 465 SER A 298 REMARK 465 GLU A 299 REMARK 465 ILE A 300 REMARK 465 LYS B 39 REMARK 465 ARG B 40 REMARK 465 GLU B 41 REMARK 465 ALA B 42 REMARK 465 GLU B 43 REMARK 465 ALA B 44 REMARK 465 THR B 297 REMARK 465 SER B 298 REMARK 465 GLU B 299 REMARK 465 ILE B 300 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 247 CB CG CD NE CZ NH1 NH2 REMARK 470 GLU A 248 CB CG CD OE1 OE2 REMARK 470 ASP A 249 CB CG OD1 OD2 REMARK 470 ARG A 280 CB CG CD NE CZ NH1 NH2 REMARK 470 ASN A 290 CG OD1 ND2 REMARK 470 PRO A 291 CB CG CD REMARK 470 GLU A 292 CB CG CD OE1 OE2 REMARK 470 ASP A 293 CB CG OD1 OD2 REMARK 470 SER A 294 CB OG REMARK 470 SER A 295 CB OG REMARK 470 ARG B 247 CB CG CD NE CZ NH1 NH2 REMARK 470 GLU B 248 CB CG CD OE1 OE2 REMARK 470 ASP B 249 CB CG OD1 OD2 REMARK 470 ARG B 280 CB CG CD NE CZ NH1 NH2 REMARK 470 ASN B 290 CG OD1 ND2 REMARK 470 PRO B 291 CB CG CD REMARK 470 GLU B 292 CB CG CD OE1 OE2 REMARK 470 ASP B 293 CB CG OD1 OD2 REMARK 470 SER B 294 CB OG REMARK 470 SER B 295 CB OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 103 NH2 ARG A 194 1.77 REMARK 500 O LEU B 230 NH1 ARG B 269 2.11 REMARK 500 O HOH A 332 O HOH A 434 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS B 214 CE LYS B 214 NZ 0.159 REMARK 500 LYS B 283 CD LYS B 283 CE 0.156 REMARK 500 LYS B 283 CE LYS B 283 NZ 0.203 REMARK 500 CYS B 296 C CYS B 296 O 0.183 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 118 108.86 -54.92 REMARK 500 ARG A 127 -32.88 66.35 REMARK 500 ILE A 128 55.61 -97.50 REMARK 500 ARG A 140 11.45 -62.15 REMARK 500 ASP A 179 -65.30 -103.64 REMARK 500 ASN A 182 47.17 -85.91 REMARK 500 ASP A 202 -122.48 65.30 REMARK 500 LYS A 214 78.19 -116.54 REMARK 500 ARG A 247 -84.07 83.93 REMARK 500 GLU A 248 133.12 110.01 REMARK 500 SER A 250 -167.96 -101.83 REMARK 500 ASN A 270 38.43 74.05 REMARK 500 GLU A 292 174.38 64.67 REMARK 500 ASP A 293 111.45 82.73 REMARK 500 SER A 294 -127.97 78.18 REMARK 500 ILE B 128 52.14 -170.27 REMARK 500 ASP B 179 -73.83 -109.11 REMARK 500 ASP B 202 -117.52 68.15 REMARK 500 ARG B 212 114.70 161.85 REMARK 500 SER B 213 30.36 -69.52 REMARK 500 VAL B 225 -52.15 -120.98 REMARK 500 HIS B 244 -173.62 -63.03 REMARK 500 GLU B 248 98.90 82.69 REMARK 500 ARG B 251 134.95 56.24 REMARK 500 ASP B 252 92.86 -32.68 REMARK 500 TYR B 279 -72.29 -76.61 REMARK 500 GLU B 292 76.26 50.73 REMARK 500 ASP B 293 82.15 173.55 REMARK 500 SER B 294 -152.67 146.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP B 164 THR B 165 -143.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NMN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NMN B 302 DBREF 2HCT A 45 300 UNP P28907 CD38_HUMAN 45 300 DBREF 2HCT B 45 300 UNP P28907 CD38_HUMAN 45 300 SEQADV 2HCT LYS A 39 UNP P28907 CLONING ARTIFACT SEQADV 2HCT ARG A 40 UNP P28907 CLONING ARTIFACT SEQADV 2HCT GLU A 41 UNP P28907 CLONING ARTIFACT SEQADV 2HCT ALA A 42 UNP P28907 CLONING ARTIFACT SEQADV 2HCT GLU A 43 UNP P28907 CLONING ARTIFACT SEQADV 2HCT ALA A 44 UNP P28907 CLONING ARTIFACT SEQADV 2HCT THR A 49 UNP P28907 ENGINEERED MUTATION SEQADV 2HCT ASP A 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 2HCT ASP A 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 2HCT ASP A 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 2HCT ASP A 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQADV 2HCT GLY A 226 UNP P28907 GLU 226 ENGINEERED MUTATION SEQADV 2HCT LYS B 39 UNP P28907 CLONING ARTIFACT SEQADV 2HCT ARG B 40 UNP P28907 CLONING ARTIFACT SEQADV 2HCT GLU B 41 UNP P28907 CLONING ARTIFACT SEQADV 2HCT ALA B 42 UNP P28907 CLONING ARTIFACT SEQADV 2HCT GLU B 43 UNP P28907 CLONING ARTIFACT SEQADV 2HCT ALA B 44 UNP P28907 CLONING ARTIFACT SEQADV 2HCT THR B 49 UNP P28907 GLN 49 ENGINEERED MUTATION SEQADV 2HCT ASP B 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 2HCT ASP B 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 2HCT ASP B 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 2HCT ASP B 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQADV 2HCT GLY B 226 UNP P28907 GLU 226 ENGINEERED MUTATION SEQRES 1 A 262 LYS ARG GLU ALA GLU ALA ARG TRP ARG GLN THR TRP SER SEQRES 2 A 262 GLY PRO GLY THR THR LYS ARG PHE PRO GLU THR VAL LEU SEQRES 3 A 262 ALA ARG CYS VAL LYS TYR THR GLU ILE HIS PRO GLU MET SEQRES 4 A 262 ARG HIS VAL ASP CYS GLN SER VAL TRP ASP ALA PHE LYS SEQRES 5 A 262 GLY ALA PHE ILE SER LYS HIS PRO CYS ASP ILE THR GLU SEQRES 6 A 262 GLU ASP TYR GLN PRO LEU MET LYS LEU GLY THR GLN THR SEQRES 7 A 262 VAL PRO CYS ASN LYS ILE LEU LEU TRP SER ARG ILE LYS SEQRES 8 A 262 ASP LEU ALA HIS GLN PHE THR GLN VAL GLN ARG ASP MET SEQRES 9 A 262 PHE THR LEU GLU ASP THR LEU LEU GLY TYR LEU ALA ASP SEQRES 10 A 262 ASP LEU THR TRP CYS GLY GLU PHE ASP THR SER LYS ILE SEQRES 11 A 262 ASN TYR GLN SER CYS PRO ASP TRP ARG LYS ASP CYS SER SEQRES 12 A 262 ASN ASN PRO VAL SER VAL PHE TRP LYS THR VAL SER ARG SEQRES 13 A 262 ARG PHE ALA GLU ALA ALA CYS ASP VAL VAL HIS VAL MET SEQRES 14 A 262 LEU ASP GLY SER ARG SER LYS ILE PHE ASP LYS ASP SER SEQRES 15 A 262 THR PHE GLY SER VAL GLY VAL HIS ASN LEU GLN PRO GLU SEQRES 16 A 262 LYS VAL GLN THR LEU GLU ALA TRP VAL ILE HIS GLY GLY SEQRES 17 A 262 ARG GLU ASP SER ARG ASP LEU CYS GLN ASP PRO THR ILE SEQRES 18 A 262 LYS GLU LEU GLU SER ILE ILE SER LYS ARG ASN ILE GLN SEQRES 19 A 262 PHE SER CYS LYS ASN ILE TYR ARG PRO ASP LYS PHE LEU SEQRES 20 A 262 GLN CYS VAL LYS ASN PRO GLU ASP SER SER CYS THR SER SEQRES 21 A 262 GLU ILE SEQRES 1 B 262 LYS ARG GLU ALA GLU ALA ARG TRP ARG GLN THR TRP SER SEQRES 2 B 262 GLY PRO GLY THR THR LYS ARG PHE PRO GLU THR VAL LEU SEQRES 3 B 262 ALA ARG CYS VAL LYS TYR THR GLU ILE HIS PRO GLU MET SEQRES 4 B 262 ARG HIS VAL ASP CYS GLN SER VAL TRP ASP ALA PHE LYS SEQRES 5 B 262 GLY ALA PHE ILE SER LYS HIS PRO CYS ASP ILE THR GLU SEQRES 6 B 262 GLU ASP TYR GLN PRO LEU MET LYS LEU GLY THR GLN THR SEQRES 7 B 262 VAL PRO CYS ASN LYS ILE LEU LEU TRP SER ARG ILE LYS SEQRES 8 B 262 ASP LEU ALA HIS GLN PHE THR GLN VAL GLN ARG ASP MET SEQRES 9 B 262 PHE THR LEU GLU ASP THR LEU LEU GLY TYR LEU ALA ASP SEQRES 10 B 262 ASP LEU THR TRP CYS GLY GLU PHE ASP THR SER LYS ILE SEQRES 11 B 262 ASN TYR GLN SER CYS PRO ASP TRP ARG LYS ASP CYS SER SEQRES 12 B 262 ASN ASN PRO VAL SER VAL PHE TRP LYS THR VAL SER ARG SEQRES 13 B 262 ARG PHE ALA GLU ALA ALA CYS ASP VAL VAL HIS VAL MET SEQRES 14 B 262 LEU ASP GLY SER ARG SER LYS ILE PHE ASP LYS ASP SER SEQRES 15 B 262 THR PHE GLY SER VAL GLY VAL HIS ASN LEU GLN PRO GLU SEQRES 16 B 262 LYS VAL GLN THR LEU GLU ALA TRP VAL ILE HIS GLY GLY SEQRES 17 B 262 ARG GLU ASP SER ARG ASP LEU CYS GLN ASP PRO THR ILE SEQRES 18 B 262 LYS GLU LEU GLU SER ILE ILE SER LYS ARG ASN ILE GLN SEQRES 19 B 262 PHE SER CYS LYS ASN ILE TYR ARG PRO ASP LYS PHE LEU SEQRES 20 B 262 GLN CYS VAL LYS ASN PRO GLU ASP SER SER CYS THR SER SEQRES 21 B 262 GLU ILE HET NMN A 301 22 HET NMN B 302 22 HETNAM NMN BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE HETSYN NMN NICOTINAMIDE MONONUCLEOTIDE FORMUL 3 NMN 2(C11 H16 N2 O8 P 1+) FORMUL 5 HOH *257(H2 O) HELIX 1 1 ARG A 58 HIS A 74 1 17 HELIX 2 2 PRO A 75 ARG A 78 5 4 HELIX 3 3 ASP A 81 ILE A 94 1 14 HELIX 4 4 THR A 102 ASP A 105 5 4 HELIX 5 5 TYR A 106 GLY A 113 1 8 HELIX 6 6 PRO A 118 LYS A 121 5 4 HELIX 7 7 ILE A 128 GLN A 139 1 12 HELIX 8 8 THR A 144 ASP A 147 5 4 HELIX 9 9 THR A 148 ASP A 155 1 8 HELIX 10 10 ASN A 183 ALA A 200 1 18 HELIX 11 11 SER A 220 VAL A 225 1 6 HELIX 12 12 VAL A 225 LEU A 230 1 6 HELIX 13 13 ASP A 252 GLN A 255 5 4 HELIX 14 14 ASP A 256 ARG A 269 1 14 HELIX 15 15 ARG A 280 ASN A 290 1 11 HELIX 16 16 ARG B 58 HIS B 74 1 17 HELIX 17 17 PRO B 75 ARG B 78 5 4 HELIX 18 18 ASP B 81 ILE B 94 1 14 HELIX 19 19 THR B 102 ASP B 105 5 4 HELIX 20 20 TYR B 106 GLY B 113 1 8 HELIX 21 21 ILE B 128 GLN B 139 1 12 HELIX 22 22 THR B 144 ASP B 147 5 4 HELIX 23 23 THR B 148 ASP B 155 1 8 HELIX 24 24 ASN B 183 ALA B 200 1 18 HELIX 25 25 SER B 220 VAL B 225 1 6 HELIX 26 26 ASP B 252 GLN B 255 5 4 HELIX 27 27 ASP B 256 ARG B 269 1 14 HELIX 28 28 ARG B 280 ASN B 290 1 11 SHEET 1 A 4 LEU A 123 SER A 126 0 SHEET 2 A 4 ASP A 202 ASP A 209 1 O HIS A 205 N LEU A 124 SHEET 3 A 4 VAL A 235 ILE A 243 1 O TRP A 241 N VAL A 206 SHEET 4 A 4 GLN A 272 ILE A 278 1 O ILE A 278 N VAL A 242 SHEET 1 B 2 GLY B 52 PRO B 53 0 SHEET 2 B 2 SER B 172 CYS B 173 -1 O CYS B 173 N GLY B 52 SHEET 1 C 4 LEU B 123 SER B 126 0 SHEET 2 C 4 ASP B 202 ASP B 209 1 O HIS B 205 N LEU B 124 SHEET 3 C 4 VAL B 235 ILE B 243 1 O THR B 237 N VAL B 204 SHEET 4 C 4 GLN B 272 ILE B 278 1 O SER B 274 N ALA B 240 SSBOND 1 CYS A 67 CYS A 82 1555 1555 2.09 SSBOND 2 CYS A 99 CYS A 180 1555 1555 2.04 SSBOND 3 CYS A 119 CYS A 201 1555 1555 2.10 SSBOND 4 CYS A 160 CYS A 173 1555 1555 2.09 SSBOND 5 CYS A 254 CYS A 275 1555 1555 2.12 SSBOND 6 CYS A 287 CYS A 296 1555 1555 2.03 SSBOND 7 CYS B 67 CYS B 82 1555 1555 2.07 SSBOND 8 CYS B 99 CYS B 180 1555 1555 2.08 SSBOND 9 CYS B 119 CYS B 201 1555 1555 2.06 SSBOND 10 CYS B 160 CYS B 173 1555 1555 2.13 SSBOND 11 CYS B 254 CYS B 275 1555 1555 2.04 SSBOND 12 CYS B 287 CYS B 296 1555 1555 2.05 SITE 1 AC1 13 TRP A 125 SER A 126 ARG A 127 LEU A 145 SITE 2 AC1 13 GLU A 146 ASP A 155 ASP A 156 TRP A 189 SITE 3 AC1 13 SER A 193 SER A 220 THR A 221 PHE A 222 SITE 4 AC1 13 HOH A 404 SITE 1 AC2 14 TRP B 125 SER B 126 ARG B 127 LYS B 129 SITE 2 AC2 14 LEU B 145 GLU B 146 ASP B 155 ASP B 156 SITE 3 AC2 14 TRP B 189 SER B 193 SER B 220 THR B 221 SITE 4 AC2 14 PHE B 222 HOH B 415 CRYST1 41.715 52.823 65.578 106.26 91.85 95.25 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023972 0.002201 0.001461 0.00000 SCALE2 0.000000 0.019011 0.005636 0.00000 SCALE3 0.000000 0.000000 0.015913 0.00000